Structure-activity relationship studies of permeability modulating peptide AT-1002

Min Li1, Ed Oliver, Kelly M Kitchens

  • 1Alba Therapeutics Corporation, 800 West Baltimore Street, Suite 400, Baltimore, MD 21201, USA.

Summary

Researchers discovered new synthetic peptides that enhance epithelial barrier permeability. These novel compounds offer improved stability while maintaining reversible transport properties, advancing drug delivery potential.